SP335RENAL FUNCTION IMPROVEMENT DUE TO REDUCTION OF HYPERURICEMIA IN CHRONIC KIDNEY DISEASE

Gout and Hyperuricemia in Chronic Kidney Disease

The grey zone of Hyperuricemia in chronic kidney disease

associations between hyperuricemia and chronic kidney disease: a review

context in human beings, uric acid is the poorly soluble circulating end product of the purine nucleotide metabolism. a reduction in the glomerular filtration rate (gfr) contributes to hyperuricemia, which is frequently observed in patients with chronic kidney disease (ckd). evidence acquisition hyperuricemia is defined as a serum uric acid level > 7.0 mg/dl in males and > 6.0 mg/dl in females,...

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease

Febuxostat is a nonpurine xanthine oxidase (XO) inhibitor, which recently received marketing approval. However, information regarding the experience with this agent among advanced chronic kidney disease (CKD) patients is limited. In the current study, we investigated the effects of oral febuxostat in patients with advanced CKD with asymptomatic hyperuricemia. We demonstrated, for the first time...

Vitamin deficiencies in chronic kidney disease